Interestingly, in an animal model of melanoma, CTLA-4 inhibition resulted in a higher proportion of TIL expressing PD-1 while PD-1 inhibition led to increased TIL expression of CTLA-4 [165]. The gene discussed is CTLA4; the disease is melanoma.